Ultralife Corporation
ULBI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $43,371 | $48,561 | $50,746 | $43,852 |
| % Growth | -10.7% | -4.3% | 15.7% | – |
| Cost of Goods Sold | $33,752 | $36,960 | $38,001 | $33,253 |
| Gross Profit | $9,619 | $11,601 | $12,745 | $10,599 |
| % Margin | 22.2% | 23.9% | 25.1% | 24.2% |
| R&D Expenses | $2,855 | $2,318 | $2,404 | $2,414 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7,715 | $7,027 | $6,942 | $6,711 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10,570 | $9,345 | $9,346 | $9,125 |
| Operating Income | -$951 | $2,256 | $3,399 | $1,474 |
| % Margin | -2.2% | 4.6% | 6.7% | 3.4% |
| Other Income/Exp. Net | -$800 | -$1,143 | -$953 | -$979 |
| Pre-Tax Income | -$1,751 | $1,113 | $2,446 | $495 |
| Tax Expense | -$504 | $243 | $567 | $262 |
| Net Income | -$1,220 | $879 | $1,865 | $194 |
| % Margin | -2.8% | 1.8% | 3.7% | 0.4% |
| EPS | -0.073 | 0.053 | 0.11 | 0.012 |
| % Growth | -238.8% | -52% | 840.2% | – |
| EPS Diluted | -0.073 | 0.053 | 0.11 | 0.012 |
| Weighted Avg Shares Out | 16,646 | 16,635 | 16,633 | 16,629 |
| Weighted Avg Shares Out Dil | 16,646 | 16,656 | 16,680 | 16,767 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $992 | $992 | $1,032 | $829 |
| Depreciation & Amortization | $1,419 | $1,418 | $1,355 | $1,179 |
| EBITDA | $660 | $3,523 | $4,833 | $2,503 |
| % Margin | 1.5% | 7.3% | 9.5% | 5.7% |